Target intelligence / Profile preview

Pathogenic bacterial adhesion to mucosa

Molecular classification
Other (not a single molecule, but a biological process involving multiple molecular interactions)
01

Overview

Pathogenic bacterial adhesion to mucosa refers to the initial and critical step in many infections where bacteria attach themselves to the mucus layer covering epithelial cells in various organs such as the respiratory and gastrointestinal tracts. This attachment is mediated by specialized bacterial surface structures called adhesins—often fimbriae or pili—which recognize and bind specific receptors on the host's mucosal surfaces[2][3]. The ability of bacteria to adhere is essential for colonization and subsequent infection. In healthy individuals, ciliary clearance helps remove adherent bacteria from respiratory mucus; however, when this defense is compromised due to injury or disease, pathogens can multiply and invade underlying tissues[1]. Some beneficial probiotic bacteria can competitively inhibit pathogenic adhesion by occupying binding sites on the mucosa[2]. While "bacterial adhesion" itself is not a discrete molecular target like an enzyme or receptor but rather a complex biological event involving multiple molecules from both pathogen and host sides, it remains an important focus for anti-infective strategies aiming at preventing colonization rather than killing pathogens directly. Note: This entry does not correspond to a single canonical molecular target but describes a multifactorial pathogenic mechanism/process. For structured drug discovery purposes, more precise targets would be individual bacterial adhesins/receptors involved in this interaction.

Other names
Bacterial adhesion to mucosal surfacesBacterial adherence to mucosaPathogen-mucosa interaction
02

Mechanism of action

Mechanisms include blocking adhesins, competitive exclusion by probiotics, or steric hindrance.

03

Biological functions

Infection initiationColonization of host tissuesEvasion of host defenses
04

Disease associations

Infection (bacterial)Chronic respiratory infectionGastrointestinal infectionUrinary tract infection
05

Safety considerations

Therapeutic targeting of adhesion could affect normal microbiota or mucosal integrity.
06

Interacting drugs

probiotics

1 more in the full profile.

07

Biomarkers

No direct biomarkers for this process; may depend on pathogen-specific factors.

Beyond the preview

Go deeper on Pathogenic bacterial adhesion to mucosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacterial adhesion to mucosa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call